 |
 |
|
What the Vienna Philharmonic Orchestra and biotech innovation have in common…
By: Reinhard Hiller, PhD
Managing Director
Centre for Proteomic and Genomic Research (CPGR)
How effective orchestration of resources can overcome the biomedical productivity crisis and unlock an African biotech revolution!
Productivity in biomedical R&D is a frequently discussed topic. Quality has been singled out as a major issue affecting productivity in the life and biomedical sciences alike; the issue is particularly rife in the technology-driven areas of Genomics and Proteomics.
I'd like to explore how R&D capacity can be organised differently, in a productivity enhancing manner. My ultimate goal is to make the case for an entirely different approach to managing Genomics and Proteomics infrastructure in Africa; and, to postulate that it is possible to achieve significant productivity gains on the continent, provided resources are utilised in a particular kind of manner.
Introduction
Imagine the orchestra pit at the ‘Musikverein’ in central Vienna (http://www.musikverein.at/). A conductor enters the pit and approaches the podium. As she walks past semi-circularly seated musicians, a feeling of uneasiness befalls her. One or two members of the brass ensemble seem to be missing; the tuba player looks as if sick to the bone. She looks at the string […]
Contact us for Dr. Reinhard Hiller's email address should you wish to contact him.
|
| |
|
|
|
|
|
|
|
|
|
|
|
UPCOMING WORKSHOP:
Open Health Innovation at the Bottom of the Pyramid:
Engaging Researchers from Africa, Latin America, SouthEast Asia
8 Module Training Workshop: 2013
Download Brochure 
WORKSHOP TOPICS
- The Role of Open innovation in Capacity Development
- North-South and Regional Partnerships-Stakeholders Engagement
- Knowledge Transfer across Partnerships
- IP Management in N-S and Regional Partnerships
- The Value of Open Source R&D
- Human Capacity Program Development
- Network Development-Clusters, Incubators, Virtual Networks
- Open Innovation Policy Development-National Systems of Innovation
WHO SHOULD ENROLL?
Stakeholders from Developed, Emerging and BoP Markets:
- Pharma
- Biotech
- Medical Devices
- BioNanotechnology
- Global Health
Roles:
- Academics-faculty, Ph.D./Masters students
- Technology Transfer Officers
- Government and Non-profit Research Institute Personnel-Researchers, Directors, Officers, Policy Makers
- Directors of Discovery, R&D, Innovation, Preclinical and Translational Research
- Directors of NGOs
|
| |
|
|
